| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.945 | 73 | 1 | 1998 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 71 | 0 | 2001 | 2020 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
phenotype | 0.100 | None | 0.958 | 71 | 1 | 1994 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
phenotype | 0.100 | None | 0.943 | 70 | 0 | 1992 | 2019 | ||||||||
|
RUNX family transcription factor 3 | 0.459 | 0.731 | 0.84 |
|
phenotype | 0.100 | None | 0.986 | 70 | 0 | 2002 | 2020 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 69 | 0 | 2006 | 2020 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
phenotype | 0.100 | None | 0.970 | 67 | 0 | 2001 | 2019 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 67 | 2 | 1994 | 2019 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 2007 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 1996 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.100 | None | 0.925 | 67 | 0 | 1995 | 2019 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.925 | 67 | 1 | 1999 | 2019 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.923 | 65 | 0 | 1997 | 2018 | ||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
phenotype | 0.100 | None | 0.938 | 64 | 0 | 2007 | 2020 | |||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.984 | 63 | 0 | 2000 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 0.935 | 62 | 0 | 2001 | 2020 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 0.984 | 62 | 0 | 1998 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
phenotype | 0.100 | None | 1.000 | 61 | 1 | 1995 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
phenotype | 0.100 | None | 0.967 | 61 | 0 | 2001 | 2020 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 0.983 | 59 | 0 | 2002 | 2020 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
phenotype | 0.100 | None | 0.983 | 59 | 1 | 1984 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
phenotype | 0.100 | None | 0.966 | 58 | 1 | 1995 | 2020 | ||||||||
|
UV radiation resistance associated | 0.436 | 0.769 | 0.99 |
|
phenotype | 0.100 | None | 0.897 | 58 | 0 | 1999 | 2019 | ||||||||
|
Rho GTPase activating protein 24 | 0.456 | 0.808 | 3.9E-10 |
|
phenotype | 0.100 | None | 0.914 | 58 | 0 | 1997 | 2018 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.100 | None | 0.982 | 57 | 2 | 1994 | 2019 |